Exhibit 99.1 InspireMD Reports Third Quarter 2025 Financial Results — Successful initial CGuard Prime U.S. commercial launch drives record quarterly revenue — Miami, FL — November 4, 2025 – InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the third quarter and nine months ended September 30, 2025. Recent Business Highlights: Marvin Slosman, CEO of InspireMD, com ...